SCHEMBL8274900

SCHEMBL8274900

C[C@H](c1ccccc1)N(C)C(=O)C(O)C(O)C(=O)NCC1CCN(c2ccccc2C#N)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 7/20 0.53
▸ CHRM4 P08173 1/20 0.43
▸ DRD2 P14416 4/20 0.40
▸ DRD4 P21917 4/20 0.40
▸ CYP2D6 P10635 2/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ NPY2R P49146 2/20 0.38
▸ DRD3 P35462 3/20 0.38
▸ PTGIR P43119 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ MC4R P32245 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8221434 1.00 ADAM17 (0.53) ADAM17CHRM4DRD2DRD4CYP2D6
SCHEMBL8273761 1.00 ADAM17 (0.53) ADAM17CHRM4DRD2DRD4CYP2D6
SCHEMBL8217095 0.90 CHRM4 (0.47) ADAM17CHRM4NPY2R
SCHEMBL8273308 0.87 ADAM17 (0.47) ADAM17PTGIRKDM4EPKM
SCHEMBL8213531 0.84 ADAM17 (0.65) ADAM17CHRM4DRD2DRD4CYP2D6
SCHEMBL8223154 0.83 CHRM4 (0.46) ADAM17CHRM4CYP2D6PTGIRKDM4E
SCHEMBL8273580 0.81 ADAM17 (0.43) ADAM17NPY2RKDM4EALDH1A1
SCHEMBL8221362 0.78 ADAM17 (0.66) ADAM17CHRM4DRD2DRD4DRD3
SCHEMBL8221461 0.77 ADAM17 (0.60) ADAM17CHRM4DRD2DRD4CYP2D6
SCHEMBL8273353 0.77 ADAM17 (0.61) ADAM17CHRM4DRD2DRD4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback